-
Systemic treatment of colon cancerŠtabuc, BorutColorectal cancer (CRC) is a second only to lung cancer as a leading cause of death from cancer. CRC alone accounts for around 200,000 deaths in Europe and represents a significant health problem. ... Although about fifty percent of patients are cured by surgery alone, the other half will eventually die due tometastatic disease, which includes approximately 25% of patients who have evidence of metastases at the time of diagnosis. Surgical resection of the primary tumor and regional lymph nodes is the only curative therapy for CRC. However, adjuvant chemotherapy in stage III. colon cancer following curative resection has been shown to reduce the risk of recurrence by 19-40% and of death by 16-33%. 5-fluorouracil and leucovorin given for six months may represent the best adjuvant treatment available today. The contribution of levamisole to adjuvant treatment seems to be marginal, if any. The benefit of adjuvant chemotherapy for the patients with Dukes B colon cancer is less clear.Vir: Gastroenterolog : revija Slovenskega združenja za gastroenterologijo in hepatologijo = journal of Slovenian Association for Gastroenterology and Hepatology. - ISSN 1408-2756 (Letn. 8, supl. 2, okt. 2004, str. 277-286)Vrsta gradiva - prispevek na konferenciLeto - 2004Jezik - angleškiCOBISS.SI-ID - 18698713
Avtor
Štabuc, Borut
Teme
Colorectal Neoplasms |
Surgery |
Drug Therapy |
Fluorouracil |
Chemotherapy, Adjuvant |
Leucovorin |
Platinum Compounds |
Neoplasm Staging |
Survival Analysis |
Thymidylate Synthetase |
Antagonists And Inhibitors |
Clinical Trials |
Fluorouracil |
Kemoterapija pomožna |
Kolorektalne novotvorbe |
Levkovorin |
Platina, spojine |
Klinične raziskave |
Novotvorba, stadij |
Preživetje, analiza |
kolon |
rektum |
kolorektum |
rak (medicina) |
zdravljenje
![loading ... loading ...](themes/default/img/ajax-loading.gif)
vir: Gastroenterolog : revija Slovenskega združenja za gastroenterologijo in hepatologijo = journal of Slovenian Association for Gastroenterology and Hepatology. - ISSN 1408-2756 (Letn. 8, supl. 2, okt. 2004, str. 277-286)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Štabuc, Borut | 11949 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi